Immunome (IMNM) News Today

IMNM fell 0.83% in the 10 minutes after this headline crossed at 16:02:21 ET on Monday, Nov 9:

Immunome says FDA set April 28, 2027, as the PDUFA target action date for varegacestat

Price 19.36 two minutes before the headline, 19.20 10 minutes after it.

Latest headline on this page:

Ask ChatGPT about IMNMAsk Claude about IMNMConnect MoveSurge to your assistant

1 headline on Immunome appeared in our news feed in the last 7 days with a measured price reaction attached. 1 of them moved the underlying at least 0.35% in the minutes after the headline crossed. The largest measured reaction was -0.83% over 10 minutes on IMNM, after the headline at Nov 9, 16:02:21 ET.

Price action when the news broke

IMNM Immunome says FDA set April 28, 2027, as the PDUFA target action date for varegacestat
MoveSurge publish 16:02:21 ET
MoveSurge publish
16:02:21 ET
19.39 19.32 19.24 19.17 19.20 16:00 16:02 16:22
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

What moved IMNM — last 7 days

Time Headline 1 min Reaction
Nov 9, 16:02:21 ET Immunome says FDA set April 28, 2027, as the PDUFA target action date for varegacestat -0.83% -0.83% · 10m

Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 15 minutes after they cross the live tape.

Related coverage

The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.